Government agency’s report stirs debate

Published: 2013-03-08 07:00:00

Updated: 2013-03-08 07:00:00

The Korea Institute for Health and Social Affairs (KIHASA), a think tank under the Prime Minister’s Office, has recently claimed in a report that the number of pharmaceutical firms should be reduced by one tenth to stem illegal rebates in the domestic pharmaceutical industry.

The institute sai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK